Profit Margin
4.96%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
7.27%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
4.26%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
8.40%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
1.25BEUR1.46B · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
21.70EURUpdated Aug 21, 2026Quarterly Revenue Growth
-2.20%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
313.90MEUR366.49M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
196.60MEUR229.54M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
62.20MEUR72.62M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
-29.70%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
144.20MEUR168.36M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
-68.39MEUR-79.85M · vs all stocks (USD) Updated Aug 21, 2026Trailing Annual Dividend Rate
1.00EURUpdated Aug 21, 2026Trailing Annual Dividend Yield
5.02%Updated Aug 21, 20265-Year Average Dividend Yield
2.60%Updated Aug 21, 2026Payout Ratio
60.38%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 94.34%.Updated Aug 21, 2026Revenue
1.27BEURFY2025 · Dec 31, 2025Cost of Goods Sold
937.10MEURFY2025 · Dec 31, 2025Gross Profit
330.30MEURFY2025 · Dec 31, 2025Operating Income
116.50MEUR136.02M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
94.90MEURFY2025 · Dec 31, 2025Income Tax Expense
20.10MEURFY2025 · Dec 31, 2025Net Income
74.80MEURFY2025 · Dec 31, 2025EBIT
110.80MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
196.60MEURFY2025 · Dec 31, 2025Research & Development
42.80MEURFY2025 · Dec 31, 2025Selling, General & Administrative
171.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
4.60MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
15.90MEURFY2025 · Dec 31, 2025EPS (Basic)
1.29EURFY2025 · Dec 31, 2025EPS (Diluted)
1.27EURFY2025 · Dec 31, 2025Basic Shares Outstanding
57.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
57.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
116.50MEURFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00EURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
91.50MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
44.70MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
116.50MEURFY2025 · Dec 31, 2025Stock-based Compensation
5.20MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.20MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.00MEURFY2025 · Dec 31, 2025Purchase of Investments
-1.90MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.90MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
2.00MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-35.30MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-10.00MEURFY2025 · Dec 31, 2025Common Dividends Paid
-37.20MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-80.50MEURFY2025 · Dec 31, 2025